Narrow search
Showing 1 - 7 of 7
Cover Image
Wirtschaftlichkeitsanalyse bei der Entwicklung von Arzneimitteln
Drummond, Michael F. - 1989
Persistent link: https://www.econbiz.de/10000078682
Cover Image
The lag between effectiveness and cost-effectiveness evidence of new drugs : implications for decision-making in health care
Stoykova, Boyka; Drummond, Michael F.; Barbieri, Marco; … - In: The European journal of health economics : HEPAC ; … 4 (2003) 4, pp. 313-318
Persistent link: https://www.econbiz.de/10001855680
Cover Image
Twenty years of using economic evaluations for reimbursement decisions what have we achieved?
Drummond, Michael F. - 2011
Persistent link: https://www.econbiz.de/10009506726
Cover Image
Is it time to reconsider the role of patient co-payments for pharmaceuticals in Europe?
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 13 (2012) 1, pp. 1-5
Persistent link: https://www.econbiz.de/10009491176
Cover Image
Reimbursement of pharmaceuticals : reference pricing versus health technology assessment
Drummond, Michael F.; Jönsson, Bengt; Rutten, F. F. H.; … - In: The European journal of health economics : HEPAC ; … 12 (2011) 3, pp. 263-271
Persistent link: https://www.econbiz.de/10009124305
Cover Image
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Cover Image
Consideration of quality of life in the health technology assessments of rare disease treatments
Nicod, Elena; Meregaglia, Michela; Whittal, Amanda; … - In: The European journal of health economics 23 (2022) 4, pp. 645-669
Persistent link: https://www.econbiz.de/10013279206